Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Effect of Tomato Nutrient Complex on Blood Pressure: A Double Blind, Randomized Doseā»Response Study.

Wolak T, Sharoni Y, Levy J, Linnewiel-Hermoni K, Stepensky D, Paran E.

Nutrients. 2019 Apr 26;11(5). pii: E950. doi: 10.3390/nu11050950.

2.

Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid.

Pesakhov S, Nachliely M, Barvish Z, Aqaqe N, Schwartzman B, Voronov E, Sharoni Y, Studzinski GP, Fishman D, Danilenko M.

Oncotarget. 2016 May 31;7(22):31847-61. doi: 10.18632/oncotarget.7240.

3.

The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity.

Linnewiel-Hermoni K, Khanin M, Danilenko M, Zango G, Amosi Y, Levy J, Sharoni Y.

Arch Biochem Biophys. 2015 Apr 15;572:28-35. doi: 10.1016/j.abb.2015.02.018. Epub 2015 Feb 21.

PMID:
25711533
4.

Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups.

Linnewiel-Hermoni K, Motro Y, Miller Y, Levy J, Sharoni Y.

Free Radic Biol Med. 2014 Oct;75:105-20. doi: 10.1016/j.freeradbiomed.2014.07.024. Epub 2014 Jul 29.

PMID:
25078119
5.

The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention.

Sharoni Y, Linnewiel-Hermoni K, Zango G, Khanin M, Salman H, Veprik A, Danilenko M, Levy J.

Am J Clin Nutr. 2012 Nov;96(5):1173S-8S. doi: 10.3945/ajcn.112.034645. Epub 2012 Oct 10. Review.

PMID:
23053550
6.

Carotenoids and apocarotenoids in cellular signaling related to cancer: a review.

Sharoni Y, Linnewiel-Hermoni K, Khanin M, Salman H, Veprik A, Danilenko M, Levy J.

Mol Nutr Food Res. 2012 Feb;56(2):259-69. doi: 10.1002/mnfr.201100311. Epub 2011 Nov 21. Review.

PMID:
22102431
7.

Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells.

Veprik A, Khanin M, Linnewiel-Hermoni K, Danilenko M, Levy J, Sharoni Y.

Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E815-24. doi: 10.1152/ajpendo.00142.2011. Epub 2011 Aug 30.

8.

The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.

Bobilev I, Novik V, Levi I, Shpilberg O, Levy J, Sharoni Y, Studzinski GP, Danilenko M.

Cancer Biol Ther. 2011 Feb 1;11(3):317-29. Epub 2011 Feb 1.

9.

Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system.

Linnewiel K, Ernst H, Caris-Veyrat C, Ben-Dor A, Kampf A, Salman H, Danilenko M, Levy J, Sharoni Y.

Free Radic Biol Med. 2009 Sep 1;47(5):659-67. doi: 10.1016/j.freeradbiomed.2009.06.008. Epub 2009 Jun 11.

PMID:
19524036
10.

Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.

Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, Levy J, Sharoni Y, Uskokovic MR, Studzinski GP, Danilenko M.

Oncology. 2008;75(3-4):203-14. doi: 10.1159/000163849. Epub 2008 Oct 14.

11.

Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients.

Walfisch S, Walfisch Y, Kirilov E, Linde N, Mnitentag H, Agbaria R, Sharoni Y, Levy J.

Eur J Cancer Prev. 2007 Aug;16(4):298-303.

PMID:
17554202
12.

Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.

Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y.

Breast Cancer Res Treat. 2007 Aug;104(2):221-30. Epub 2006 Oct 19.

PMID:
17051425
13.

Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1.

Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, Levy J, Sharoni Y.

Eur J Nutr. 2006 Aug;45(5):275-82. Epub 2006 Mar 24.

PMID:
16565789
14.

Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.

Sharabani H, Izumchenko E, Wang Q, Kreinin R, Steiner M, Barvish Z, Kafka M, Sharoni Y, Levy J, Uskokovic M, Studzinski GP, Danilenko M.

Int J Cancer. 2006 Jun 15;118(12):3012-21.

15.

Carotenoids activate the antioxidant response element transcription system.

Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, Levy J.

Mol Cancer Ther. 2005 Jan;4(1):177-86.

16.

Carotenoids and transcription.

Sharoni Y, Danilenko M, Dubi N, Ben-Dor A, Levy J.

Arch Biochem Biophys. 2004 Oct 1;430(1):89-96. Review.

PMID:
15325915
17.

Modulation of transcriptional activity by antioxidant carotenoids.

Sharoni Y, Agbaria R, Amir H, Ben-Dor A, Bobilev I, Doubi N, Giat Y, Hirsh K, Izumchenko G, Khanin M, Kirilov E, Krimer R, Nahum A, Steiner M, Walfisch Y, Walfisch S, Zango G, Danilenko M, Levy J.

Mol Aspects Med. 2003 Dec;24(6):371-84. Review.

PMID:
14585308
18.
20.

Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.

Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M.

Nutr Cancer. 2001;41(1-2):135-44.

PMID:
12094616
21.

Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation.

Hirsch K, Danilenko M, Giat J, Miron T, Rabinkov A, Wilchek M, Mirelman D, Levy J, Sharoni Y.

Nutr Cancer. 2000;38(2):245-54.

PMID:
11525603
22.

Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells.

Ben-Dor A, Nahum A, Danilenko M, Giat Y, Stahl W, Martin HD, Emmerich T, Noy N, Levy J, Sharoni Y.

Arch Biochem Biophys. 2001 Jul 15;391(2):295-302.

PMID:
11437362
24.

Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.

Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y.

Nutr Cancer. 2000;36(1):101-11.

PMID:
10798222
25.

Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells.

Amir H, Karas M, Giat J, Danilenko M, Levy R, Yermiahu T, Levy J, Sharoni Y.

Nutr Cancer. 1999;33(1):105-12.

PMID:
10227052
26.

Do changes in growth hormone levels correlate with IGF-I levels in patients undergoing IVF-ET?

Yohay D, Lunenfeld E, Giat Y, Levy J, Sharoni Y, Potashnik G, Glezerman M.

Gynecol Endocrinol. 1997 Aug;11(4):269-74.

PMID:
9272424
28.

Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors.

Sharoni Y, Giron E, Rise M, Levy J.

Cancer Detect Prev. 1997;21(2):118-23.

PMID:
9101071
29.
30.

Maternal plasma and amniotic fluid cortisol and progesterone concentrations between women with and without term labor. A comparison.

Ohana E, Mazor M, Chaim W, Levy J, Sharoni Y, Leiberman JR, Glezerman M.

J Reprod Med. 1996 Feb;41(2):80-6.

PMID:
8656419
31.

The assembly of neutrophil NADPH oxidase: effects of mastoparan and its synthetic analogues.

Tisch D, Sharoni Y, Danilenko M, Aviram I.

Biochem J. 1995 Sep 1;310 ( Pt 2):715-9.

32.

Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol.

Kleinman D, Karas M, Roberts CT Jr, LeRoith D, Phillip M, Segev Y, Levy J, Sharoni Y.

Endocrinology. 1995 Jun;136(6):2531-7.

PMID:
7750475
33.

Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation.

Potashnik G, Lunenfeld E, Shwartz I, Glezerman M, Roberts CT Jr, LeRoith D, Sharoni Y, Levy J.

Hum Reprod. 1995 May;10(5):1065-9.

PMID:
7657742
34.

Components of the IGF system mediate the opposing effects of tamoxifen on endometrial and breast cancer cell growth.

Karas M, Kleinman D, Danilenko M, Roberts CT Jr, LeRoith D, Levy J, Sharoni Y.

Prog Growth Factor Res. 1995;6(2-4):513-20.

PMID:
8817696
35.

Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene.

Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y.

Nutr Cancer. 1995;24(3):257-66.

PMID:
8610045
36.

Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis.

Kleinman D, Douvdevani A, Schally AV, Levy J, Sharoni Y.

Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):96-102.

PMID:
8296852
37.

Selective effects of mastoparan analogs: separation of G-protein-directed and membrane-perturbing activities.

Danilenko M, Worland P, Carlson B, Sausville EA, Sharoni Y.

Biochem Biophys Res Commun. 1993 Nov 15;196(3):1296-302.

PMID:
8250884
38.

Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75.

Kleinman D, Roberts CT Jr, LeRoith D, Schally AV, Levy J, Sharoni Y.

Regul Pept. 1993 Oct 20;48(1-2):91-8.

PMID:
8265821
39.

Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.

Hershkovitz E, Marbach M, Bosin E, Levy J, Roberts CT Jr, LeRoith D, Schally AV, Sharoni Y.

J Clin Endocrinol Metab. 1993 Oct;77(4):963-8.

PMID:
8408472
40.

Estrogen and progesterone receptors in the uterine artery of rats during and after pregnancy.

Leiberman JR, Wiznitzer A, Glezerman M, Feldman B, Levy J, Sharoni Y.

Eur J Obstet Gynecol Reprod Biol. 1993 Sep;51(1):35-40.

PMID:
8282141
41.

Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth.

Dobrzanski D, Sharoni Y, Wada E, Battey J, Sausville E.

Regul Pept. 1993 Jun 11;45(3):341-52.

PMID:
8394594
42.

The relationship between estrogen/progesterone ratio and term human parturition.

Mazor M, Wiznitzer A, Levy J, Sharoni Y, Meril Z, Minster A, Glezerman M.

Isr J Med Sci. 1993 Feb-Mar;29(2-3):97-9. No abstract available.

PMID:
8468179
43.

Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue.

Sion-Vardi N, Kaneti J, Segal-Abramson T, Giat J, Levy J, Sharoni Y.

J Urol. 1992 Nov;148(5):1568-70.

PMID:
1331544
44.

Guanine nucleotide modulation of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors.

Segal-Abramson T, Giat J, Levy J, Sharoni Y.

Mol Cell Endocrinol. 1992 May;85(1-2):109-16.

PMID:
1326449
45.

Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.

Segal-Abramson T, Kitroser H, Levy J, Schally AV, Sharoni Y.

Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2336-9.

46.

Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer.

Viallet J, Sharoni Y, Frucht H, Jensen RT, Minna JD, Sausville EA.

J Clin Invest. 1990 Dec;86(6):1904-12.

48.

Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.

Sharoni Y, Bosin E, Miinster A, Levy J, Schally AV.

Proc Natl Acad Sci U S A. 1989 Mar;86(5):1648-51.

49.

Differential distribution of protein kinases along the crypt-to-lumen regions of rat colonic epithelium.

Schwartz B, Fraser GM, Levy J, Sharoni Y, Guberman R, Krawiec J, Lamprecht SA.

Gut. 1988 Sep;29(9):1213-21.

50.

[The autocrine regulation of growth in breast cancer].

Israeli E, Sharoni Y, Levy J.

Harefuah. 1988 Jul;115(1-2):19-24. Review. Hebrew. No abstract available.

PMID:
3047026

Supplemental Content

Loading ...
Support Center